Filing Details
- Accession Number:
- 0001209191-19-003938
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-16 16:31:23
- Reporting Period:
- 2019-01-14
- Accepted Time:
- 2019-01-16 16:31:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645113 | Novocure Ltd | NVCR | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1654435 | Asaf Danziger | C/O Novocure Inc. 20 Valley Stream Parkway, Suite 300 Malvern PA 19355 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2019-01-14 | 100,000 | $3.44 | 271,164 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-01-14 | 100,000 | $43.52 | 171,164 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2019-01-15 | 100,000 | $3.44 | 271,164 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2019-01-15 | 100,000 | $43.49 | 171,164 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2019-01-14 | 100,000 | $0.00 | 100,000 | $3.44 |
| Ordinary Shares | Options to Buy Ordinary Shares | Disposition | 2019-01-15 | 100,000 | $0.00 | 100,000 | $3.44 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 346,863 | 2021-12-13 | No | 4 | M | Direct | |
| 246,863 | 2021-12-13 | No | 4 | M | Direct |
Footnotes
- These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.
- On January 14, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 100,000 shares in multiple trades at prices ranging from $43.44 to $43.66. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- On January 15, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger, Mr. Danziger sold 100,000 shares in multiple trades at prices ranging from $43.44 to $43.92. The price reported above reflects the weighted average sale price. Mr. Danziger hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
- Fully vested and currently exercisable as of the date hereof.
Billionaire Hedge Funds
